2021 will prove to be pivotal for the pot market. Investors stand to rake in huge gains. And today we have a new play that will allow you to take advantage of the hype.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
There’s a lot going on in COVID-19 research right now. A recent report by the Department of Homeland Security details dozens of companies developing tools to diagnose, treat and prevent the spread of this virus. As you know we’ve made several COVID-19 recommendations in Technology Profits Confidential. So far, they are all firmly in the running.
They say you can’t stop the power of an idea whose time has come. And as it turns out, if the idea comes attached to a stock, you can’t stop it from going up either. This September, as stocks have sold off, this medical device play has been bucking the trend and just killing it.
With Apple’s “One More Thing” event behind us, today I want to jump right into the mailbag. In it, I'll answer questions crucial to any and all Apple-fi developments.
Patients treated with this biotech’s antibody cocktail showed substantial improvement compared to patients given a placebo.
With the latest iPhone reveal behind us, 5G is all people can talk about. And to support that trend, we have a track record of wireless techs and products to give you the best bang for your buck. Today, I am going to reveal one 5G play that looks to not only benefit off the technology… But also off the current consumer environment.
What can we expect in the coming months? Sounds like another round of stimulus, an aggressive COVID-19 vaccination plan and rejoining the Paris climate agreement are on the horizon… amongst many other things. But at the end of the day, no matter who you voted for, the one thing you shouldn’t worry about is your tech portfolio.